Showing 481 - 500 results of 872 for search '"preclinical"', query time: 0.06s Refine Results
  1. 481

    FDA-approved kinase inhibitors: a promising therapeutic avenue for traumatic brain injury by Dezhu Gao, Yu Shi, Zhiliang Wang, Weiming Liu

    Published 2024-12-01
    “…Nowadays, kinase inhibitors approved by the Food and Drug Administration (FDA) mainly for cancer treatment have shown potential effects in TBI. Preclinical studies suggest their potential in promoting recovery. …”
    Get full text
    Article
  2. 482

    The role of DNA methylation in the disorders of bone metabolism by B. I. Yalaev, A. V. Tyurin, R. Y. Mirgalieva, R. I. Khusainova

    Published 2019-02-01
    “…Finding the risk factors will predict the risk of osteoporosis at the preclinical stage, help define the course and severity of the disease, and develop preventive measures based on them to reduce the risk of fractures. …”
    Get full text
    Article
  3. 483

    Cultured Human Airway Epithelial Cells (Calu-3): A Model of Human Respiratory Function, Structure, and Inflammatory Responses by Yan Zhu, Aaron Chidekel, Thomas H. Shaffer

    Published 2010-01-01
    “…The Calu-3 cell preparation is a sensitive and efficient preclinical model to study human respiratory processes and diseases related to oxygen- and ventilator-induced lung injury.…”
    Get full text
    Article
  4. 484
  5. 485

    CAR T cells for treating autoimmune diseases by Dimitrios Mougiakakos, Ulrike Koehl, Stephan Fricke, Ulrich Blache, Sandy Tretbar

    Published 2023-11-01
    “…We will cover first clinical results of applying anti-CD19 and anti-B cell maturation antigen CAR T cells for B cell elimination in systemic lupus erythematosus, refractory antisynthetase syndrome and myasthenia gravis, respectively. Furthermore, in preclinical models, researchers have also developed chimeric autoantibody receptor T cells that can eliminate individual B cell clones producing specific autoantibodies, and regulatory CAR T cells that do not eliminate autoreactive immune cells but dampen their wrong activation. …”
    Get full text
    Article
  6. 486

    Structure-guided identification of mitogen-activated protein kinase-1 inhibitors towards anticancer therapeutics. by Md Nayab Sulaimani, Shazia Ahmed, Farah Anjum, Taj Mohammad, Anas Shamsi, Ravins Dohare, Md Imtaiyaz Hassan

    Published 2025-01-01
    “…The study highlights that these compounds could be explored further in preclinical and clinical investigations to develop anticancer therapeutics.…”
    Get full text
    Article
  7. 487

    Herbal medicine and leptospirosis in Southeast Asia: A comprehensive bibliometric analysis (1973-2023) by Shah Putri Ade Dian, Stefani Widodo, Putri Damayanti Irma, Halim Shariff, Abidah Safithri, Muhammad Almanfaluthi

    Published 2025-01-01
    “…The research also emphasizes the role of preclinical studies and the chemical analysis of herbal remedies for leptospirosis. …”
    Get full text
    Article
  8. 488

    Dual Inhibition of Activin/Nodal/TGF-β and BMP Signaling Pathways by SB431542 and Dorsomorphin Induces Neuronal Differentiation of Human Adipose Derived Stem Cells by Vedavathi Madhu, Abhijit S. Dighe, Quanjun Cui, D. Nicole Deal

    Published 2016-01-01
    “…Damage to the nervous system can cause devastating diseases or musculoskeletal dysfunctions and transplantation of progenitor stem cells can be an excellent treatment option in this regard. Preclinical studies demonstrate that untreated stem cells, unlike stem cells activated to differentiate into neuronal lineage, do not survive in the neuronal tissues. …”
    Get full text
    Article
  9. 489
  10. 490

    Rheological Characterization and Printability of Sodium Alginate–Gelatin Hydrogel for 3D Cultures and Bioprinting by Mohan Kumar Dey, Ram V. Devireddy

    Published 2025-01-01
    “…The development of biocompatible hydrogels for 3D bioprinting is essential for creating functional tissue models and advancing preclinical drug testing. This study investigates the formulation, printability, mechanical properties, and biocompatibility of a novel Alg-Gel hydrogel blend (alginate and gelatin) for use in extrusion-based 3D bioprinting. …”
    Get full text
    Article
  11. 491

    Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects by Flávia De C. Cartolano, Gabriela D. Dias, Maria C. P. de Freitas, Antônio M. Figueiredo Neto, Nágila R. T. Damasceno

    Published 2017-01-01
    “…Atherogenic diabetes is associated with an increased cardiovascular risk and mortality in diabetic individuals; however, the impact of insulin resistance (IR) in lipid metabolism in preclinical stages is generally underreported. For that, we evaluated the capacity of IR to predict an atherogenic lipid subfraction profile. …”
    Get full text
    Article
  12. 492

    Gene Editing in Pluripotent Stem Cells and Their Derived Organoids by Hang Zhou, Yun Wang, Li-Ping Liu, Yu-Mei Li, Yun-Wen Zheng

    Published 2021-01-01
    “…The applications, characteristics, and existing challenges are summarized in combination with our lab experiences in this field in an effort to help gene-editing technology better serve humans in a regulated manner. Current preclinical and clinical trials have demonstrated initial safety and efficacy of PSC gene editing; however, for better application in clinical settings, additional investigation is warranted.…”
    Get full text
    Article
  13. 493

    Advancements in lung regeneration: from bench to bedside by Danial Khayatan, Peyman Esmaeili Fard Barzegar, Arooj Fatima, Tayyaba Sattar, Ambreen Zahid, Syeda Aiman Batool, Mehreen Jabbar, Maryam Mureed, Fatima Haider, Aymun Javed Butt, Sana Hanif, Alexander Seifalian, Hamid Tebyaniyan

    Published 2025-02-01
    “…By critical analysis of in vitro, preclinical, and clinical studies, this review aims to provide a comprehensive overview of the emerging technology of lung regeneration research, shedding light on promising avenues for future therapeutic interventions.…”
    Get full text
    Article
  14. 494

    Human Liver Stem Cells Suppress T-Cell Proliferation, NK Activity, and Dendritic Cell Differentiation by Stefania Bruno, Cristina Grange, Marta Tapparo, Chiara Pasquino, Renato Romagnoli, Ennia Dametto, Antonio Amoroso, Ciro Tetta, Giovanni Camussi

    Published 2016-01-01
    “…Human liver stem cells (HLSCs) are a mesenchymal stromal cell-like population resident in the adult liver. Preclinical studies indicate that HLSCs could be a good candidate for cell therapy. …”
    Get full text
    Article
  15. 495

    Determination of Muscone in Rats Plasma following Oral Administration of Artificial Musk: Using of Combined Headspace Gas Chromatography-Mass Spectrometry by Qibiao Wu, Haitao Li, Yujing Leng, Haishan Deng, Haibo Cheng, Weixing Shen

    Published 2014-01-01
    “…This method would be applicable to the analysis of plasma concentrations of muscone in preclinical contexts, where artificial musk is used.…”
    Get full text
    Article
  16. 496

    In vivo MRI visualization of growth and morphology in the orthotopic xenotrasplantation U87 glioblastoma mouse SCID model by E. L. Zavjalov, I. A. Razumov, L. A. Gerlinskaya, A. V. Romashchenko

    Published 2015-12-01
    “…The results demonstrate that this SCID model may be used as an in vivo preclinical model to test the efficacy and putative side effects of novel anticancer therapies.…”
    Get full text
    Article
  17. 497

    Mushroom β-glucan and polyphenol formulations as natural immunity boosters and balancers: nature of the application by Maja Kozarski, Anita Klaus, Leo van Griensven, Dragica Jakovljevic, Nina Todorovic, Wan Abd Al Qadr Imad Wan-Mohtar, Jovana Vunduk

    Published 2023-03-01
    “…The literature data on their bioavailability, metabolic transformations, preclinical and human clinical research, and safety are discussed. …”
    Get full text
    Article
  18. 498

    Targeted therapeutic strategies for Nectin-4 in breast cancer: Recent advances and future prospects by Yufei Wang, Guangliang Li, Hanying Wang, Quan Qi, Xian Wang, Haiqi Lu

    Published 2025-02-01
    “…Notably, Nectin-4 was also investigated as a target for breast cancer in preclinical and clinical settings. Nectin-4-targeted approaches, such as ADCs, oncolytic viruses, photothermal therapy and immunotherapy, have shown promising results in early-phase clinical trials. …”
    Get full text
    Article
  19. 499

    The Role of Gut Microbiota in Tumor Immunotherapy by Miao Wu, Jiawei Bai, Chengtai Ma, Jie Wei, Xianjin Du

    Published 2021-01-01
    “…These characteristics may be used as biomarkers to predict the prognosis of immunotherapy and may also be developed as “immune potentiators” to assist immunotherapy. Some clinical and preclinical studies have proved that microbial intervention, including microbial transplantation, can improve the sensitivity of immunotherapy or reduce adverse reactions to a certain extent. …”
    Get full text
    Article
  20. 500

    Combination of GLP-1 Receptor Activation and Glucagon Blockage Promotes Pancreatic β-Cell Regeneration In Situ in Type 1 Diabetic Mice by Liangbiao Gu, Dandan Wang, Xiaona Cui, Tianjiao Wei, Kun Yang, Jin Yang, Rui Wei, Tianpei Hong

    Published 2021-01-01
    “…Glucagon receptor (GCGR) monoclonal antibody (mAb), a preclinical agent that blocks glucagon pathway, can promote the recovery of functional β-cell mass in type 1 diabetic mice. …”
    Get full text
    Article